THE EFFECT OF SERUM-LIPID REGULATION ON THE DEVELOPMENT OF FEMORAL ATHEROSCLEROSIS IN HYPERLIPEMIA - A NONRANDOMIZED CONTROLLED-STUDY

被引:41
作者
OLSSON, AG
RUHN, G
ERIKSON, U
机构
[1] KING GUSTAF V RES INST,STOCKHOLM,SWEDEN
[2] UNIV HOSP UPPSALA,DEPT DIAGNOST RADIOL,UPPSALA,SWEDEN
关键词
atheroma; femoral atherosclerosis; fenofibrate; hyperlipidaemia; nicotinic acid; regression; serum lipoproteins;
D O I
10.1111/j.1365-2796.1990.tb00176.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Abstract. The development of femoral atheroma after 1 year of treatment with diet and nicotinic acid plus fenofibrate was studied in 45 asymptomatic, hyperlipidaemic, middle‐aged male subjects in a non‐randomized controlled study. The median serum very low density lipoprotein (VLDL) cholesterol concentration and the low density lipoprotein (LDL) cholesterol concentration were lowered by 67% and 36%, respectively, in the treatment group. The median serum high density lipoprotein (HDL) cholesterol concentration was increased by 23%. Femoral atheroma was estimated by overall atherosclerosis score (OAS). Changes in femoral atherosclerosis were estimated by intrapair comparison of angiograms. Progression was found in 24% and 40% in the treatment and control groups, respectively. Regression occurred in 29% and 0%, respectively. The OAS decrease correlated with reductions in VLDL cholesterol and systolic blood pressure. 1990 Blackwell Publishing Ltd
引用
收藏
页码:381 / 390
页数:10
相关论文
共 16 条
[1]  
ANDERSSON P S, 1987, Lasers in Medical Science, V2, P261, DOI 10.1007/BF02594170
[2]   DIET, LIPOPROTEINS, AND THE PROGRESSION OF CORONARY ATHEROSCLEROSIS - THE LEIDEN INTERVENTION TRIAL [J].
ARNTZENIUS, AC ;
KROMHOUT, D ;
BARTH, JD ;
REIBER, JHC ;
BRUSCHKE, AVG ;
BUIS, B ;
VANGENT, CM ;
KEMPENVOOGD, N ;
STRIKWERDA, S ;
VANDERVELDE, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (13) :805-811
[3]   PREVALENCE OF ASYMPTOMATIC FEMORAL-ARTERY ATHEROMAS IN HYPERLIPOPROTEINEMIC PATIENTS [J].
BARNDT, R ;
BLANKENHORN, DH ;
CRAWFORD, DW .
ATHEROSCLEROSIS, 1974, 20 (02) :253-262
[4]   REGRESSION AND PROGRESSION OF EARLY FEMORAL ATHEROSCLEROSIS IN TREATED HYPERLIPOPROTEINEMIC PATIENTS [J].
BARNDT, R ;
BLANKENHORN, DH ;
CRAWFORD, DW ;
BROOKS, SH .
ANNALS OF INTERNAL MEDICINE, 1977, 86 (02) :139-146
[5]  
BEAUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891
[6]   BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS [J].
BLANKENHORN, DH ;
NESSIM, SA ;
JOHNSON, RL ;
SANMARCO, ME ;
AZEN, SP ;
CASHINHEMPHILL, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23) :3233-3240
[7]   EFFECTS OF THERAPY WITH CHOLESTYRAMINE ON PROGRESSION OF CORONARY ARTERIOSCLEROSIS - RESULTS OF THE NHLBI TYPE-II CORONARY INTERVENTION STUDY [J].
BRENSIKE, JF ;
LEVY, RI ;
KELSEY, SF ;
PASSAMANI, ER ;
RICHARDSON, JM ;
LOH, IK ;
STONE, NJ ;
ALDRICH, RF ;
BATTAGLINI, JW ;
MORIARTY, DJ ;
FISHER, MR ;
FRIEDMAN, L ;
FRIEDEWALD, W ;
DETRE, KM ;
EPSTEIN, SE .
CIRCULATION, 1984, 69 (02) :313-324
[8]  
CARLSON K, 1973, J CLIN PATHOL S5, V26, P32
[9]  
DUFFIELD RGM, 1983, LANCET, V2, P639
[10]  
ERIKSON U, 1988, ACTA RADIOL, V29, P303